I now have all the information needed for a comprehensive answer. Let me compile it.
Vitamin B12 Deficiency with Subacute Combined Degeneration of the Spinal Cord
i) Nutritional Deficiency and Probable Diagnosis (2 marks)
Nutritional Deficiency: Vitamin B12 (Cobalamin) deficiency - caused by strict vegetarianism, as B12 is found exclusively in animal-source foods (meat, dairy, eggs, fish). A strict vegetarian who avoids all animal products will develop B12 deficiency over months to years as body stores (typically 2-5 mg) are gradually depleted.
Probable Diagnosis:
- Megaloblastic (Macrocytic) Anemia - due to impaired DNA synthesis in erythroid precursors
- Subacute Combined Degeneration (SCD) of the Spinal Cord - demyelination of the dorsal and lateral columns of the spinal cord due to B12 deficiency
This combination of megaloblastic anemia + neurological deficits in a strict vegetarian is the classic presentation of nutritional cobalamin deficiency.
ii) Correlation of Symptoms, Signs, and Lab Reports (3 marks)
Symptoms and Their Basis
| Symptom/Sign | Pathophysiological Explanation |
|---|
| Extreme weakness and fatigue | Megaloblastic anemia reduces O2-carrying capacity. Large, dysfunctional RBCs (macrocytes) are produced due to impaired DNA synthesis, leading to ineffective erythropoiesis and anemia. The pallor on examination confirms this. |
| Numbness and heaviness in lower limbs | SCD of the spinal cord: B12 deficiency causes demyelination of the posterior columns (loss of vibration sense, proprioception - numbness, sensory ataxia) and lateral (corticospinal) columns (upper motor neuron signs - weakness/heaviness, spasticity). |
| Motor and sensory loss in both legs | Combined posterior + lateral column involvement. Posterior column: sensory loss. Lateral column: pyramidal tract demyelination causing motor weakness. The peripheral nerves may also show axonal degeneration, contributing to sensory loss. |
| Pallor | Anemia from ineffective erythropoiesis - large abnormal RBCs are destroyed in the bone marrow before release (intramedullary hemolysis). |
Lab Correlation
-
Large-sized RBCs (macrocytes) on peripheral smear: B12 is required for DNA synthesis. Without it, nuclear maturation is delayed while cytoplasmic maturation (hemoglobinization) continues normally - a phenomenon called nuclear-cytoplasmic dissociation. Cells grow larger but cannot divide, resulting in macrocytes (MCV > 100 fL). The smear typically also shows oval macrocytes and hypersegmented neutrophils (5 or more lobes). This is the hallmark of megaloblastic anemia.
-
Elevated urinary methylmalonic acid (MMA): B12 (as adenosylcobalamin) is a cofactor for the enzyme L-methylmalonyl-CoA mutase, which converts L-methylmalonyl-CoA to succinyl-CoA. In B12 deficiency, this reaction is blocked - methylmalonyl-CoA accumulates and is hydrolyzed to methylmalonic acid, which spills into the urine. Elevated MMA >400 nmol/L is highly specific for cobalamin deficiency (not seen in folate deficiency alone, making it a key differentiator). - Goldman-Cecil Medicine
-
Elevated homocysteine: B12 (as methylcobalamin) is required by methionine synthase, which converts homocysteine + methyl-THF → methionine + THF. In B12 deficiency, this reaction is blocked, causing homocysteine to accumulate in blood and urine. Note: homocysteine is elevated in both B12 AND folate deficiency (and pyridoxine deficiency), so it is less specific than MMA. The combination of elevated MMA + elevated homocysteine is diagnostic for cobalamin deficiency. - Goldman-Cecil Medicine, Table 150-3
iii) Additional Lab Investigations for Definitive Diagnosis (2 marks)
- Serum Vitamin B12 (cobalamin) level - directly measures B12; low values (<200 pg/mL) confirm deficiency (though the 200-350 pg/mL "grey zone" requires metabolite testing for confirmation)
- Complete Blood Count (CBC) - reveals macrocytic anemia (high MCV), possible pancytopenia (low WBC, low platelets), low hemoglobin
- Peripheral Blood Smear - hypersegmented neutrophils (≥1 neutrophil with 6 lobes, or ≥5% with 5 lobes), oval macrocytes - pathognomonic of megaloblastic anemia
- Serum Folate and Red Cell Folate - to differentiate B12 from folate deficiency (both cause megaloblastic anemia, but only B12 deficiency causes neurological involvement and elevated MMA)
- Bone Marrow Examination - hypercellular marrow with megaloblastic erythroid precursors, giant metamyelocytes, nuclear-cytoplasmic dissociation (the "gold standard" morphological confirmation)
- Serum Lactate Dehydrogenase (LDH) and Indirect Bilirubin - elevated due to intramedullary hemolysis (ineffective erythropoiesis)
- Reticulocyte count - low/normal (reticulocytopenia), which distinguishes this from hemolytic anemia
- Anti-intrinsic factor antibodies and anti-parietal cell antibodies - to rule out pernicious anemia (autoimmune gastritis) as an underlying cause (relevant even in vegetarians)
- Serum gastrin - elevated in atrophic gastritis/pernicious anemia
- MRI of spinal cord - may show signal changes (hyperintensity on T2) in posterior and lateral columns in SCD
iv) Biochemical Explanation of Lab Findings (5 marks)
Biochemical Basis of Elevated Methylmalonic Acid
B12 in the form of adenosylcobalamin serves as a coenzyme for L-methylmalonyl-CoA mutase:
Propionyl-CoA → D-methylmalonyl-CoA → L-methylmalonyl-CoA → Succinyl-CoA
↑
[Adenosylcobalamin-dependent]
In B12 deficiency:
- The mutase reaction is blocked
- L-methylmalonyl-CoA accumulates and is hydrolyzed to methylmalonic acid
- MMA is excreted in urine (and also elevated in serum)
- This pathway is unique to B12 - folate plays no role - making elevated MMA a B12-specific marker
Biochemical Basis of Elevated Homocysteine
B12 in the form of methylcobalamin is required by methionine synthase:
Homocysteine + Methyl-THF → Methionine + THF
↑
[Methylcobalamin-dependent]
In B12 deficiency:
- Methionine synthase activity drops sharply
- Homocysteine accumulates (elevated in blood and urine)
- Methyl-THF cannot donate its methyl group → methyl-THF "traps" → secondary folate deficiency (the "methyl-folate trap")
- THF is not regenerated → reduced substrate for thymidylate synthase → impaired thymidine synthesis → impaired DNA synthesis
Biochemical Basis of Macrocytic Anemia (Large RBCs)
The methyl-folate trap leads to:
- Reduced 5,10-methylene-THF (a cofactor for thymidylate synthase)
- Impaired conversion of dUMP → dTMP (thymidine)
- Uracil incorporation into DNA instead of thymine
- DNA strand breaks, impaired DNA repair, prolonged cell cycle
- Nuclear maturation arrest in erythroid precursors
- Cytoplasm continues to grow (hemoglobin synthesis is not affected) → nuclear-cytoplasmic dissociation
- Result: large, immature RBC precursors (megaloblasts) → macrocytes released into circulation (or destroyed intramedullary = ineffective erythropoiesis)
Biochemical Basis of Neurological Damage (SCD)
Two proposed mechanisms:
- SAM depletion: Reduced methionine (from blocked methionine synthase) → reduced S-adenosylmethionine (SAM). SAM is the universal methyl donor needed for methylation of myelin basic protein and phospholipids essential for myelin sheath integrity. Without SAM-dependent methylation, myelin breaks down → demyelination of posterior and lateral columns
- MMA accumulation: MMA may directly impair fatty acid synthesis in myelin and act as a competitive inhibitor of normal metabolites, contributing to the neuropathy
The result is subacute combined degeneration - named because:
- Subacute - develops over months
- Combined - involves both posterior columns (sensory) AND lateral columns (motor/pyramidal tracts)
- Degeneration - progressive demyelination and axonal loss - Bradley and Daroff's Neurology
The posterior column damage explains: loss of vibration sense, proprioception, sensory ataxia, and numbness.
The lateral (corticospinal tract) damage explains: motor weakness, heaviness, spasticity, and upper motor neuron signs.
v) Treatment Plan (3 marks)
Immediate Treatment - Parenteral Vitamin B12
Since this patient has neurological involvement (SCD), parenteral (intramuscular) administration is preferred to ensure reliable absorption, bypassing any potential absorption issues:
Standard Regimen (Bradley and Daroff's Neurology):
- Week 1: Cyanocobalamin or hydroxocobalamin 1000 μg IM daily × 7 days
- Weeks 2-4: 1000 μg IM weekly × 4 weeks
- Maintenance: 1000 μg IM monthly for life (if dietary cause is not corrected) OR lifelong oral supplementation at 1000 μg/day if adherence is ensured
Note: In the UK, hydroxocobalamin is preferred; in the US, cyanocobalamin is standard. Both are effective. - Harrison's, Katzung
Oral Supplementation (Alternative)
For purely dietary deficiency (as in this strict vegetarian), high-dose oral B12 (1000-2000 μg/day) can also be effective, even in patients with absorption concerns, because ~1% of oral cobalamin is absorbed by passive diffusion (not dependent on intrinsic factor). This is a reasonable long-term maintenance strategy once the patient is repleted.
Dietary Modification
- Counsel the patient to include animal products (dairy, eggs at minimum if not fully vegan) or take fortified foods
- For those who remain strict vegans: lifelong B12 supplementation is non-negotiable
Do NOT Give Folate Alone
If megaloblastic anemia is due to B12 deficiency, giving folic acid alone will correct the hematological picture (masking the diagnosis) but will allow neurological damage to progress silently and irreversibly. Always confirm the cause before treating.
Monitoring Response
- Hematological response: Reticulocyte count rises within 3-5 days of treatment; MCV normalizes over weeks; hemoglobin normalizes in 6-8 weeks
- Biochemical response: Serum MMA and homocysteine return to normal within approximately 2 weeks of treatment - Bradley and Daroff's Neurology
- Neurological response: Improvement begins within 1-3 months; most symptomatic improvement occurs within the first 6-12 months. Neurological recovery is inversely related to the duration of deficiency - early treatment is essential for maximum recovery
Supportive Care
- Physiotherapy for lower limb weakness and gait rehabilitation
- Fall prevention measures while neurological recovery is underway
- Monitor potassium levels during initial treatment (rapid cell production can cause hypokalemia - "hungry cell syndrome")
Sources: Goldman-Cecil Medicine (Table 150-3, Cobalamin Deficiency section); Bradley and Daroff's Neurology in Clinical Practice (Ch. 85); Harrison's Principles of Internal Medicine 22E; Katzung Basic and Clinical Pharmacology 16E; Robbins & Kumar Basic Pathology.